141
Views
2
CrossRef citations to date
0
Altmetric
Review

Benefit risk assessment and update on the use of docetaxel in the management of breast cancer

&
Pages 357-365 | Published online: 14 Oct 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sundaram Subramanian, Rammohan Prasanna, Ghanashyam Biswas, Saroj Kumar Das Majumdar, Nisarg Joshi, Deepak Bunger, Mujtaba A Khan & Imran Ahmad. (2020) Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study. Breast Cancer: Targets and Therapy 12, pages 77-85.
Read now
Simona Serini, Roberta Cassano, Sonia Trombino & Gabriella Calviello. (2019) Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases. International Journal of Nanomedicine 14, pages 2809-2828.
Read now